Charles River Laboratories (CRL) stock price, revenue, and financials

Charles River Laboratories market cap is $16.4 b, and annual revenue was $2.92 b in FY 2020

$16.4 B

CRL Mkt cap, 24-Jan-2022

$895.9 M

Charles River Laboratories Revenue Q3, 2021
Charles River Laboratories Gross profit (Q3, 2021)337.2 M
Charles River Laboratories Gross profit margin (Q3, 2021), %37.6%
Charles River Laboratories Net income (Q3, 2021)105.2 M
Charles River Laboratories EBIT (Q3, 2021)155.8 M
Charles River Laboratories Cash, 25-Sept-2021212.5 M
Charles River Laboratories EV19.3 B
Get notified regarding key financial metrics and revenue changes at Charles River LaboratoriesLearn more
Banner background

Charles River Laboratories Revenue

Charles River Laboratories revenue was $2.92 b in FY, 2020 which is a 11.5% year over year increase from the previous period.

Embed Graph

Charles River Laboratories Revenue Breakdown

Embed Graph

Charles River Laboratories revenue breakdown by business segment: 17.6% from Manufacturing, 62.8% from DSA and 19.5% from RMS

Charles River Laboratories revenue breakdown by geographic segment: 28.4% from Europe, 55.6% from US, 5.3% from Asia Pacific, 10.5% from Canada and 0.2% from Other

Charles River Laboratories Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020

Revenue

2.3b2.6b2.9b

Revenue growth, %

22%16%12%

Cost of goods sold

1.4b1.7b1.9b

Gross profit

840.1m958.3m1.1b

Gross profit Margin, %

37%37%37%

General and administrative expense

443.9m517.6m528.9m

Operating expense total

508.7m607.2m640.8m

Depreciation and amortization

64.8m89.5m111.9m

EBIT

331.4m351.2m432.7m

EBIT margin, %

15%13%15%

Interest expense

63.8m60.9m86.4m

Interest income

812.0k1.5m834.0k

Pre tax profit

281.7m304.1m447.1m

Income tax expense

54.5m50.0m81.8m

Net Income

228.7m254.1m365.3m

EPS

4.65.17.2

Charles River Laboratories Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020

Cash

195.4m238.0m228.4m

Accounts Receivable

472.2m514.0m617.7m

Prepaid Expenses

53.4m52.6m96.7m

Inventories

127.9m160.7m185.7m

Current Assets

897.8m1.0b1.2b

PP&E

932.9m1.0b1.1b

Goodwill

1.2b1.5b1.8b

Total Assets

3.9b4.7b5.5b

Accounts Payable

66.3m111.5m122.5m

Short-term debt

31.4m38.5m50.2m

Current Liabilities

558.2m710.2m839.8m

Long-term debt

1.6b2.0b2.1b

Total Debt

1.7b2.0b2.1b

Total Liabilities

2.5b3.0b3.3b

Common Stock

482.0k489.0k498.0k

Additional Paid-in Capital

1.4b1.5b1.6b

Retained Earnings

42.1m280.3m625.4m

Total Equity

1.3b1.6b2.1b

Debt to Equity Ratio

1.3 x1.2 x1 x

Debt to Assets Ratio

0.4 x0.4 x0.4 x

Financial Leverage

2.9 x2.9 x2.6 x

Charles River Laboratories Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020

Net Income

228.7m254.1m365.3m

Depreciation and Amortization

161.8m198.1m234.9m

Accounts Receivable

(21.2m)(8.3m)(85.6m)

Inventories

(13.3m)(21.4m)(18.4m)

Accounts Payable

(12.7m)29.8m748.0k

Cash From Operating Activities

441.1m480.9m546.6m

Purchases of PP&E

(140.1m)(140.5m)(166.6m)

Cash From Investing Activities

(955.0m)(681.5m)(601.5m)

Long-term Borrowings

(2.2b)(3.1b)(2.2b)

Cash From Financing Activities

558.1m231.9m47.2m

Net Change in Cash

31.0m42.7m(6.9m)

Interest Paid

47.5m67.8m72.5m

Income Taxes Paid

67.6m54.1m60.1m

Charles River Laboratories Ratios

USDFY, 2018

EV/EBIT

20.7 x

EV/CFO

15.5 x

Revenue/Employee

154.2k

Debt/Equity

1.3 x

Debt/Assets

0.4 x

Financial Leverage

2.9 x

P/E Ratio

24.2

Charles River Laboratories Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020

Backlog (DSA)

$590 m$900.8 m$1 b$1.4 b

Backlog (Manufacturing)

$46.9 m$74.4 m$65.4 m$79.2 m

Backlog (RMS)

$96.8 m$106.5 m$128.7 m$167.6 m

Countries

23202020

Facilities

808090100

Strains

150150150150

Charles River Laboratories Human Capital

FY, 2020FY, 2019FY, 2018
Female, percent58.7%58.3%58%
Male, percent41.3%41.7%42%

Charles River Laboratories Employee Rating

3.31062 votes
Culture & Values
3.3
Work/Life Balance
3.2
Senior Management
3
Salary & Benefits
3.3
Career Opportunities
3.2
Source